CRP and cancer: In various gynecological and non-gynecological human cancers, the conventional biochemical or hematological markers routinely measured in common blood tests or as ratios derived from these measurements (CRP, WBC, ESR, calculated inflammatory cell-derived indices or ratios) have been intensively assessed not only for confirmation of the presence of inflammation but also as prognostic factors [7,8,9,10,11].